3
Views
5
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Analysis of the Fibroblast Transformation Potential of GTPase-Deficient gip2 Oncogenes

, , , , , & show all
Pages 190-197 | Received 01 Aug 1991, Accepted 07 Oct 1991, Published online: 01 Apr 2023
 

Abstract

Expression of GTPase-deficient Gi2 α subunit (αi2) mutant polypeptides and overexpression of the wild-type αi2 polypeptide in Rat la, Swiss 3T3, and NIH 3T3 fibroblasts altered normal growth regulation and induced a loss of contact inhibition. In Rat la cells (but not in NIH 3T3 or Swiss 3T3 cells), expression of the GTPase-deficient αi2 mutant polypeptides allowed colony formation in soft agar, which correlated with a loss in anchorage dependence and a decreased serum requirement. The altered growth regulatory properties of Rat la cells induced by expression of αi2 mutant polypeptides was not significantly inhibited by cotransfection with a dominant negative Ha-ras mutant polypeptide (Asn-17rasH), indicating that the activated Gi2 membrane signal transduction protein is uniquely capable of altering the regulation of Rat la cell growth by a predominantly c-ras-independent mechanism. The results show that GTPase-deficient αi2 mutant polypeptides have the properties of an oncogene that can induce the phenotypic characteristics of transformation in Rat la cells but that only a subset of these changes is observed with NIH 3T3 and Swiss 3T3 cells.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.